Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Chemistry  (2)
  • Key Words Angiogenesis  (1)
  • 1
    ISSN: 1615-6692
    Keywords: Schlüsselwörter Angiogenese ; Wachstumsfaktoren ; Koronare Herzkrankheit ; Key Words Angiogenesis ; Growth factors ; Coronary heart disease
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract Currently available approaches for treating human coronary heart disease aim to relieve symptoms and the risk of myocardial infarction either by reducing myocardial oxygen demand, preventing further disease progression, restoring coronary blood flow pharmacologically or mechanically, or bypassing the stenotic lesions and obstructed coronary artery segments. Gene therapy, especially using angiogenic growth factors, has emerged recently as a potential new treatment for cardiovascular disease. Following extensive experimental research on angiogenic growth factors, the first clinical studies on patients with coronary heart disease and peripheral vascular lesions have been performed. The polypeptides fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) appear to be particularly effective in initiating neovascularization (neoangiogenesis) in hypoxic or ischemic tissues. The first clinical study on patients with coronary heart disease treated by local intramyocardial injection of FGF-1 showed a 3-fold increase of capillary density mediated by the growth factor. Also, angiogenic growth factor injection intramyocardially as sole therapy for end-stage coronary disease showed an improvement of myocardial perfusion in the target areas as well as a reduction of symptoms and an increase in working capacity. Angiogenic therapy of the human myocardium introduces a new modality of treatment for coronary heart disease in terms of regulation of blood vessel growth. Beyond drug therapy, angioplasty and bypass surgery, this new approach may evolve into a fourth principle of treatment of atherosclerotic cardiovascular disease.
    Notes: Zusammenfassung Ziele der aktuellen Behandlungsmethoden der koronaren Herzkrankheit sind eine Minimierung des Infarktrisikos und eine Reduktion der Symptome. Dies wird erreicht durch Senkung des myokardialen Sauerstoffbedarfs, durch Prävention einer weiteren Progression der Erkrankung und durch eine Verbesserung der koronaren Durchblutung sowohl medikamentös als auch mechanisch durch PTCA und Bypasschirurgie. Die Gentherapie der koronaren Herzkrankheit, insbesondere die Gentherapie mit Verwendung sogenannter angiogenetisch wirksamer Wachstumsfaktoren, hat sich in jüngster Zeit zu einer neuen potentiellen Behandlungsmethode bei kardiovaskulären Erkrankungen entwickelt. Nach umfangreichen experimentellen Untersuchungen zur Wirksamkeit angiogener Wachstumsfaktoren wurden in jüngster Zeit die ersten klinischen Studien durchgeführt, die diese neue Behandlungsmethode bei peripherer arterieller Verschlusskrankheit und bei koronarer Herzkrankheit anwandten. Die Polypeptide Fibroblast Growth Factor (FGF) und Vascular Endothelial Growth Factor (VEGF) scheinen einen besonders starken Effekt hinsichtlich der Induktioneiner Neoangiogenese in hypoxischen oder ischämischen Geweben zu haben. Die erste klinische Studie bei Patienten mit koronarer Herzkrankheit setzte FGF-1 als zusätzliche Maßnahme im Rahmen der Bypasschirurgie ein; in dieser Studie konnte eine um das Dreifache erhöhte kapilläre Dichte im Bereich der intramyokardialen Applikation des Wachstumsfaktors nachgewiesen werden. Auch die intramyokardiale Applikation angiogenetischer Wachstumsfaktoren als Monotherapie bei terminaler koronarer Herzkrankheit zeigte in ersten Studien sowohl eine verbesserte lokale Perfusion im behandelten Myokard als auch eine Reduktion der klinischen Symptomatik und eine verbesserte Belastbarkeit der behandelten Patienten. Die Induktion der Neoangiogenese durch humane angiogenetische Wachstumsfaktoren stellt – neben medikamentöser Therapie, PTCA und Bypasschirurgie – eine neue Therapiemodalität für die koronare Herzkrankheit dar, insbesondere bei solchen pathologischen Befunden, bei denen herkömmliche Therapieverfahren nicht oder nicht ausreichend wirksam sind.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    New York, NY [u.a.] : Wiley-Blackwell
    Journal of Applied Polymer Science 4 (1960), S. 207-211 
    ISSN: 0021-8995
    Keywords: Chemistry ; Polymer and Materials Science
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology , Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics
    Notes: The reaction of toylene diisocyanate (80/20 mixture of 2,4 and 2,6-isomer) with a secondary hydroxyl-containing polyoxypropylene triol was studied in the presence of numerous compounds to test their catalytic effect on the reaction. The reaction was studied by determination of the gelation time of the reaction mixture. Many metallic compounds were found to be good catalysts for the isocyanate-hydroxyl reaction. Compounds in roughly descending catalytic activity are: Bi, Pb, Sn, triethylenediamine, strong bases, Ti, Fe, Sb, U, Cd, Co, Th, Al, Hg, Zn, Ni, trialkylamines, Ce, Mo, V, Cu, Mn, Zr, trialkyl phosphines. Similar gelation tests were made with m-xylene diisocyanate and the same triol and also with hexamethylene diisocyanate and the triol. In these tests the order of strength of the catalysts was found to be different than when tolylene diisocyanate was used. In decreasing order of activity: Bi, Fe, Sn, Pb, Ti, Sb, strong bases, Co, Zn, triethylenediamine, trialkyl amines. A mechanism is proposed for the way in which a metal compound may catalyze the isocyanate-hydroxyl reaction. Steric hinderance is suggested to explain the differing catalytic activity observed with tolylene diisocyanate and the unhindered aliphatic diisocyanates.
    Additional Material: 11 Tab.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Stamford, Conn. [u.a.] : Wiley-Blackwell
    Polymer Engineering and Science 3 (1963), S. 117-122 
    ISSN: 0032-3888
    Keywords: Chemistry ; Chemical Engineering
    Source: Wiley InterScience Backfile Collection 1832-2000
    Topics: Chemistry and Pharmacology , Mechanical Engineering, Materials Science, Production Engineering, Mining and Metallurgy, Traffic Engineering, Precision Mechanics , Physics
    Notes: Variations were made in the concentration of tin and amine catalysts used in a typical one-short polyether flexible foam system. Differences in foaming characteristics and foam stability were correlated with the relative rates of the chemical reactions which are believed to occur during the foaming process. Physical properties measured on the samples showed in many cases a dependence on the balance between the tin and amine catalysts.
    Additional Material: 7 Ill.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...